vVARDIS raises €31.5M Series A round
11 February 2025· Zug, Switzerland· health, dental_care, biomimetic, biotech, deep_tech, b2b
The capital will support the company's growth initiatives and global commercial expansion of its innovative drill-free treatment for early tooth decay, Curodont™.
Investors
LeadOrbiMed
About vVARDIS
Stage
Series C
Headquarters
Zug, Switzerland
Founded
2003
Team Size
51–200
Sectors
healthdental_carebiomimeticbiotechdeep_techb2b